13F

Stock

Prime Medicine, Inc.

PRME · held by 13 managers

Reported value

$32.3M

Holders

13

+3 new · −0 exited

Holders’ est. mark

$355.9K

Price effect on 3 books still in the name

Largest holder

$26.3M

FARALLON CAPITAL MANAGEMENT LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
FARALLON CAPITAL MANAGEMENT LLC4.75M$26.3MNew
MORGAN STANLEY731K$4.05MHeld
BARCLAYS PLC115.9K$642.1K$352.4KAdded$358.5K
BANK OF AMERICA CORP /DE/110.8K$614.1KHeld
TUDOR INVESTMENT CORP ET AL63K$348.9KHeld
PEAK6 LLC35.1K$194.2KNew
Sanctuary Advisors, LLC14.3K$79.3KNew
Hudson Bay Capital Management LP13K$72.2KHeld
Allworth Financial LP1.01K$5.57KHeld
Leonteq Securities AG915$5.07K$2.81KAdded$2.81K
Scarborough Advisors, LLC505$2.8KHeld
Essential Partners LLC210$1.16K$644Added$644
IFP Advisors, Inc9$50Held

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.